Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Joe E. who wrote (2674)	11/7/1997 2:10:00 AM
From: billkirn	Read Replies (2) of 6136

John: Heard the same info at meeting. 1st Q on European. Also stated time line 2001 for ag3340. Little heart to heart with director and he is very excited about progress. Very interesting and unique about 3340; no side effects yet found, dosing levels just about established, and the most important thing is that it will be taken with normal treatment methods so enrollment will be easy to obtain. I got the feeling ag3340 is something very special, and will beat their public time lines. I still really respect Peter Johnson. My money is in the right place for the long term. Bill

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next